Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients

Circulating tumor cells (CTC) are prognostic in metastatic breast cancer (MBC). The CTC-endocrine therapy index (CTC-ETI), consisting of CTC-ER (estrogen receptor), BCL2, human epidermal growth factor receptor (HER2), and Ki67 expression, might predict resistance to endocrine therapy (ET) in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Paoletti, Costanza, Regan, Meredith M., Niman, Samuel M., Dolce, Emily M., Darga, Elizabeth P., Liu, Minetta C., Marcom, P. Kelly, Hart, Lowell L., Smith, John W., Tedesco, Karen L., Amir, Eitan, Krop, Ian E., DeMichele, Angela M., Goodwin, Pamela J., Block, Margaret, Aung, Kimberly, Brown, Martha E., McCormack, Robert T., Hayes, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196036/
https://www.ncbi.nlm.nih.gov/pubmed/34117261
http://dx.doi.org/10.1038/s41523-021-00281-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196036/
https://www.ncbi.nlm.nih.gov/pubmed/34117261
http://dx.doi.org/10.1038/s41523-021-00281-1

Ejemplares similares